Ming-Song Lee

Ming-Song Lee

Auto-generated profile, based on publicly available information

Ming-Song Lee

Department of Orthopedics and Rehabilitation, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
MLMing-Song Lee
Ming-Song Lee
MSMatthew J. Stebbins
Matthew J. Stebbins
HJHongli Jiao
Hongli Jiao
HHHui-Ching Huang
Hui-Ching Huang
ELEllen M. Leiferman
Ellen M. Leiferman
WLWan-Ju Li
Wan-Ju Li
Inspired by how cartilage is developed, stem cell derivatives forming facial and articular cartilage are studied for joint repair.

16 November 2022 in Science Advances
Verified
Journal Article
Open access
NCNgai Ting Chan
Ngai Ting Chan
MLMing-Song Lee
Ming-Song Lee
YWYidan Wang
Yidan Wang
JGJacques Galipeau
Jacques Galipeau
WLWan-Ju Li
Wan-Ju Li
WXWei Xu
Wei Xu
Cell fate determination of human mesenchymal stem/stromal cells (hMSCs) is precisely regulated by lineage-specific transcription factors and epigenetic enzymes. We found that CTR9, a key scaffold subunit of polymerase-associated factor complex (PAFc), selectively regulates hMSC differentiation to osteoblasts and chondrocytes, but not to adipocytes. An in vivo ectopic osteogenesis assay confirmed the essentiality of CTR9 in hMSC-derived bone formation. CTR9 counteracts the activity of Enhancer Of Zeste 2 (EZH2), the epigenetic enzyme that deposits H3K27me3, in hMSCs. Accordingly, CTR9 knockdown (KD) hMSCs gain H3K27me3 mark, and the osteogenic differentiation defects of CTR9 KD hMSCs can be partially rescued by treatment with EZH2 inhibitors. Transcriptome analyses identified bone morphology protein–2 (BMP-2) as a downstream effector of CTR9. BMP-2 secretion, membrane anchorage, and the BMP-SMAD pathway were impaired in CTR9 KD MSCs, and the effects were rescued by BMP-2 supplementation. This study uncovers an epigenetic mechanism engaging the CTR9–H3K27me3–BMP-2 axis to regulate the osteochondral lineage differentiation of hMSCs.

1 September 2021 in CARTILAGE
Verified
Journal Article
Closed access
PDF file
BWBrian E. Walczak
Brian E. Walczak
HJHongli Jiao
Hongli Jiao
MLMing-Song Lee
Ming-Song Lee
WLWan-Ju Li
Wan-Ju Li
Functions of mesenchymal stem/stromal cells (MSCs) are affected by patient-dependent factors such as age and health condition. To tackle this problem, we used the cellular reprogramming technique to epigenetically alter human MSCs derived from the synovial fluid of joints with osteoarthritis (OA) to explore the potential of reprogrammed MSCs for repairing articular cartilage. MSCs isolated from the synovial fluid of three patients’ OA knees (Pa-MSCs) were reprogrammed through overexpression of pluripotency factors and then induced for differentiation to establish reprogrammed MSC (Re-MSC) lines. We compared the in vitro growth characteristics, chondrogenesis for articular cartilage chondrocytes, and immunomodulatory capacity. We also evaluated the capability of Re-MSCs to repair articular cartilage damage in an animal model with spontaneous OA. Our results showed that Re-MSCs increased the in vitro proliferative capacity and improved chondrogenic differentiation toward articular cartilage-like chondrocyte phenotypes with increased THBS4 and SIX1 and decreased ALPL and COL10A1, compared to Pa-MSCs. In addition, Re-MSC-derived chondrocytes expressing elevated COL2A and COL2B were more mature than parental cell-derived ones. The enhancement in chondrogenesis of Re-MSC involves the upregulation of sonic hedgehog signaling. Moreover, Re-MSCs improved the repair of articular cartilage in an animal model of spontaneous OA. Epigenetic reprogramming promotes MSCs harvested from OA patients to increase phenotypic characteristics and gain robust functions. In addition, Re-MSCs acquire an enhanced potential for articular cartilage repair. Our study here demonstrates that the reprogramming strategy provides a potential solution to the challenge of variation in MSC quality.